메뉴 건너뛰기




Volumn 12, Issue 1, 2013, Pages 133-144

Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies

Author keywords

Glucocorticoid receptor; Leukemia; Lymphoma; Multiple myeloma; Proteasome inhibitor; Selective GR activator (SEGRA)

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTINEOPLASTIC AGENT; BORTEZOMIB; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; SELECTIVE GLUCOCORTICOID RECEPTOR ACTIVATOR; UNCLASSIFIED DRUG;

EID: 84872307569     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23048     Document Type: Article
Times cited : (24)

References (54)
  • 1
    • 55049108455 scopus 로고
    • The use of adrenocorticotropic hormone and cortisone in the treatment of leukemia and leukosarcoma
    • PMID:14869344
    • Rosenthal MC, Saunders RH, Schwartz LI, Zannos L, Perez Santiago E, Dameshek W. The use of adrenocorticotropic hormone and cortisone in the treatment of leukemia and leukosarcoma. Blood 1951; 6:804-23; PMID:14869344.
    • (1951) Blood , vol.6 , pp. 804-823
    • Rosenthal, M.C.1    Saunders, R.H.2    Schwartz, L.I.3    Zannos, L.4    Perez Santiago, E.5    Dameshek, W.6
  • 2
    • 0037383192 scopus 로고    scopus 로고
    • Characterization of the MM.1 human multiple myeloma (MM) cell lines: A model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells
    • PMID:12691914
    • Greenstein S, Krett NL, Kurosawa Y, Ma C, Chauhan D, Hideshima T, et al. Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells. Exp Hematol 2003; 31:271-82; PMID:12691914; http://dx.doi.org/10.1016/S0301-472X(03)00023-7.
    • (2003) Exp Hematol , vol.31 , pp. 271-282
    • Greenstein, S.1    Krett, N.L.2    Kurosawa, Y.3    Ma, C.4    Chauhan, D.5    Hideshima, T.6
  • 3
    • 82155178738 scopus 로고    scopus 로고
    • Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma
    • quiz 5982; PMID:21849487
    • Moreau P, Avet-Loiseau H, Facon T, Attal M, Tiab M, Hulin C, et al. Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma. Blood 2011; 118:5752-8, quiz 5982; PMID:21849487; http://dx.doi.org/10.1182/blood-2011-05-355081.
    • (2011) Blood , vol.118 , pp. 5752-5758
    • Moreau, P.1    Avet-Loiseau, H.2    Facon, T.3    Attal, M.4    Tiab, M.5    Hulin, C.6
  • 4
    • 53049083867 scopus 로고    scopus 로고
    • Mechanisms of proteasome inhibitor action and resistance in cancer
    • PMID:18818117
    • McConkey DJ, Zhu K. Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist Updat 2008; 11:164-79; PMID:18818117; http://dx.doi.org/10.1016/j.drup.2008.08.002.
    • (2008) Drug Resist Updat , vol.11 , pp. 164-179
    • McConkey, D.J.1    Zhu, K.2
  • 5
    • 80555156759 scopus 로고    scopus 로고
    • Glucocorticoid receptor-mediated apoptosis: Mechanisms of resistance in cancer cells
    • PMID:21602312
    • Schlossmacher G, Stevens A, White A. Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells. J Endocrinol 2011; 211:17-25; PMID:21602312; http://dx.doi.org/10.1530/JOE-11-0135.
    • (2011) J Endocrinol , vol.211 , pp. 17-25
    • Schlossmacher, G.1    Stevens, A.2    White, A.3
  • 6
    • 34547883532 scopus 로고    scopus 로고
    • The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin
    • PMID:17538956
    • Chebotaev D, Yemelyanov A, Budunova I. The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin. Mol Carcinog 2007; 46:732-40; PMID:17538956; http://dx.doi.org/10.1002/mc.20349.
    • (2007) Mol Carcinog , vol.46 , pp. 732-740
    • Chebotaev, D.1    Yemelyanov, A.2    Budunova, I.3
  • 7
    • 0034931702 scopus 로고    scopus 로고
    • Glucocorticoid-regulated transcription factors
    • PMID:11448148
    • Adcock IM. Glucocorticoid-regulated transcription factors. Pulm Pharmacol Ther 2001; 14:211-9; PMID:11448148; http://dx.doi.org/10.1006/pupt.2001.0283.
    • (2001) Pulm Pharmacol Ther , vol.14 , pp. 211-219
    • Adcock, I.M.1
  • 8
    • 79953726304 scopus 로고    scopus 로고
    • Glucocorticosteroids: Current and future directions
    • PMID:21198556
    • Barnes PJ. Glucocorticosteroids: current and future directions. Br J Pharmacol 2011; 163:29-43; PMID:21198556; http://dx.doi.org/10.1111/j.1476-5381. 2010.01199.x.
    • (2011) Br J Pharmacol , vol.163 , pp. 29-43
    • Barnes, P.J.1
  • 9
    • 26944451363 scopus 로고    scopus 로고
    • Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells
    • PMID:16113441
    • Necela BM, Cidlowski JA. Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proc Am Thorac Soc 2004; 1:239-46; PMID:16113441; http://dx.doi.org/10.1513/pats.200402-005MS.
    • (2004) Proc Am Thorac Soc , vol.1 , pp. 239-246
    • Necela, B.M.1    Cidlowski, J.A.2
  • 10
    • 0041324898 scopus 로고    scopus 로고
    • The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: Molecular mechanisms for gene repression
    • PMID:12920152
    • De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 2003; 24:488-522; PMID:12920152; http://dx.doi.org/10.1210/er.2002-0006.
    • (2003) Endocr Rev , vol.24 , pp. 488-522
    • De Bosscher, K.1    Vanden Berghe, W.2    Haegeman, G.3
  • 11
    • 33947500218 scopus 로고    scopus 로고
    • Tumor suppressor activity of glucocorticoid receptor in the prostate
    • PMID:17016446
    • Yemelyanov A, Czwornog J, Chebotaev D, Karseladze A, Kulevitch E, Yang X, et al. Tumor suppressor activity of glucocorticoid receptor in the prostate. Oncogene 2007; 26:1885-96; PMID:17016446; http://dx.doi.org/10.1038/sj.onc. 1209991.
    • (2007) Oncogene , vol.26 , pp. 1885-1896
    • Yemelyanov, A.1    Czwornog, J.2    Chebotaev, D.3    Karseladze, A.4    Kulevitch, E.5    Yang, X.6
  • 12
    • 34248342981 scopus 로고    scopus 로고
    • The tumor suppressor effect of the glucocorticoid receptor in skin is mediated via its effect on follicular epithelial stem cells
    • PMID:17146443
    • Chebotaev D, Yemelyanov A, Zhu L, Lavker RM, Budunova I. The tumor suppressor effect of the glucocorticoid receptor in skin is mediated via its effect on follicular epithelial stem cells. Oncogene 2007; 26:3060-8; PMID:17146443; http://dx.doi.org/10.1038/sj.onc.1210108.
    • (2007) Oncogene , vol.26 , pp. 3060-3068
    • Chebotaev, D.1    Yemelyanov, A.2    Zhu, L.3    Lavker, R.M.4    Budunova, I.5
  • 13
    • 0347719371 scopus 로고    scopus 로고
    • Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects
    • PMID:14694204
    • Schäcke H, Schottelius A, Döcke WD, Strehlke P, Jaroch S, Schmees N, et al. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci USA 2004; 101:227-32; PMID:14694204; http://dx.doi.org/10.1073/pnas.0300372101.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 227-232
    • Schäcke, H.1    Schottelius, A.2    Döcke, W.D.3    Strehlke, P.4    Jaroch, S.5    Schmees, N.6
  • 14
    • 70350125299 scopus 로고    scopus 로고
    • Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases
    • PMID:19422381
    • Schäcke H, Zollner TM, Döcke WD, Rehwinkel H, Jaroch S, Skuballa W, et al. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases. Br J Pharmacol 2009; 158:1088-103; PMID:19422381; http://dx.doi.org/ 10.1111/j.1476-5381.2009.00238.x.
    • (2009) Br J Pharmacol , vol.158 , pp. 1088-1103
    • Schäcke, H.1    Zollner, T.M.2    Döcke, W.D.3    Rehwinkel, H.4    Jaroch, S.5    Skuballa, W.6
  • 15
    • 79960702498 scopus 로고    scopus 로고
    • The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation
    • PMID:21558312
    • Hu X, Du S, Tunca C, Braden T, Long KR, Lee J, et al. The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation. Endocrinology 2011; 152:3123-34; PMID:21558312; http://dx.doi.org/10.1210/en.2010-1447.
    • (2011) Endocrinology , vol.152 , pp. 3123-3134
    • Hu, X.1    Du, S.2    Tunca, C.3    Braden, T.4    Long, K.R.5    Lee, J.6
  • 16
    • 0037780901 scopus 로고    scopus 로고
    • Biological activities of the shrub Salsola tuberculatiformis Botsch.: Contraceptive or stress alleviator?
    • PMID:12766951
    • Swart P, Swart AC, Louw A, van der Merwe KJ. Biological activities of the shrub Salsola tuberculatiformis Botsch.: contraceptive or stress alleviator? Bioessays 2003; 25:612-9; PMID:12766951; http://dx.doi.org/10.1002/bies.10285.
    • (2003) Bioessays , vol.25 , pp. 612-619
    • Swart, P.1    Swart, A.C.2    Louw, A.3    Van Der Merwe, K.J.4
  • 17
    • 27644492383 scopus 로고    scopus 로고
    • A fully dissociated compound of plant origin for inflammatory gene repression
    • PMID:16243974
    • De Bosscher K, Vanden Berghe W, Beck IM, Van Molle W, Hennuyer N, Hapgood J, et al. A fully dissociated compound of plant origin for inflammatory gene repression. Proc Natl Acad Sci USA 2005; 102:15827-32; PMID:16243974; http://dx.doi.org/10.1073/pnas.0505554102.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 15827-15832
    • De Bosscher, K.1    Vanden Berghe, W.2    Beck, I.M.3    Van Molle, W.4    Hennuyer, N.5    Hapgood, J.6
  • 18
    • 49649107285 scopus 로고    scopus 로고
    • Novel steroid receptor phytomodulator compound a inhibits growth and survival of prostate cancer cells
    • PMID:18559523
    • Yemelyanov A, Czwornog J, Gera L, Joshi S, Chatterton RT Jr., Budunova I. Novel steroid receptor phytomodulator compound a inhibits growth and survival of prostate cancer cells. Cancer Res 2008; 68:4763-73; PMID:18559523; http://dx.doi.org/10.1158/0008-5472.CAN-07-6104.
    • (2008) Cancer Res , vol.68 , pp. 4763-4773
    • Yemelyanov, A.1    Czwornog, J.2    Gera, L.3    Joshi, S.4    Chatterton Jr., R.T.5    Budunova, I.6
  • 19
    • 40849142555 scopus 로고    scopus 로고
    • A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis
    • PMID:18250472
    • Dewint P, Gossye V, De Bosscher K, Vanden Berghe W, Van Beneden K, Deforce D, et al. A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis. J Immunol 2008; 180:2608-15; PMID:18250472.
    • (2008) J Immunol , vol.180 , pp. 2608-2615
    • Dewint, P.1    Gossye, V.2    De Bosscher, K.3    Vanden Berghe, W.4    Van Beneden, K.5    Deforce, D.6
  • 20
    • 77950892860 scopus 로고    scopus 로고
    • Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a
    • PMID:20037160
    • Robertson S, Allie-Reid F, Vanden Berghe W, Visser K, Binder A, Africander D, et al. Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a. J Biol Chem 2010; 285:8061-75; PMID:20037160; http://dx.doi.org/10.1074/jbc.M109.087866.
    • (2010) J Biol Chem , vol.285 , pp. 8061-8075
    • Robertson, S.1    Allie-Reid, F.2    Vanden Berghe, W.3    Visser, K.4    Binder, A.5    Africander, D.6
  • 21
    • 75149156175 scopus 로고    scopus 로고
    • Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis
    • PMID:19965930
    • van Loo G, Sze M, Bougarne N, Praet J, Mc Guire C, Ullrich A, et al. Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis. Mol Endocrinol 2010; 24:310-22; PMID:19965930; http://dx.doi.org/10.1210/me. 2009-0236.
    • (2010) Mol Endocrinol , vol.24 , pp. 310-322
    • Van Loo, G.1    Sze, M.2    Bougarne, N.3    Praet, J.4    Mc Guire, C.5    Ullrich, A.6
  • 22
    • 77949524864 scopus 로고    scopus 로고
    • Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis
    • PMID:19997594
    • Wüst S, Tischner D, John M, Tuckermann JP, Menzfeld C, Hanisch UK, et al. Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis. PLoS One 2009; 4:e8202; PMID:19997594; http://dx.doi.org/10.1371/journal.pone.0008202.
    • (2009) PLoS One , vol.4
    • Wüst, S.1    Tischner, D.2    John, M.3    Tuckermann, J.P.4    Menzfeld, C.5    Hanisch, U.K.6
  • 23
    • 78650850288 scopus 로고    scopus 로고
    • Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells
    • PMID:21084452
    • Rauner M, Goettsch C, Stein N, Thiele S, Bornhaeuser M, De Bosscher K, et al. Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells. Endocrinology 2011; 152:103-12; PMID:21084452; http://dx.doi.org/10.1210/en. 2010-0456.
    • (2011) Endocrinology , vol.152 , pp. 103-112
    • Rauner, M.1    Goettsch, C.2    Stein, N.3    Thiele, S.4    Bornhaeuser, M.5    De Bosscher, K.6
  • 24
    • 0029855029 scopus 로고    scopus 로고
    • Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression
    • PMID:8895760
    • Geley S, Hartmann BL, Hala M, Strasser-Wozak EM, Kapelari K, Kofler R. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression. Cancer Res 1996; 56:5033-8; PMID:8895760.
    • (1996) Cancer Res , vol.56 , pp. 5033-5038
    • Geley, S.1    Hartmann, B.L.2    Hala, M.3    Strasser-Wozak, E.M.4    Kapelari, K.5    Kofler, R.6
  • 25
    • 84862965339 scopus 로고    scopus 로고
    • Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: A novel therapeutic modality
    • PMID:22223138
    • Yemelyanov A, Bhalla P, Yang X, Ugolkov A, Iwadate K, Karseladze A, et al. Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality. Cell Cycle 2012; 11:395-406; PMID:22223138; http://dx.doi.org/10.4161/cc.11.2. 18945.
    • (2012) Cell Cycle , vol.11 , pp. 395-406
    • Yemelyanov, A.1    Bhalla, P.2    Yang, X.3    Ugolkov, A.4    Iwadate, K.5    Karseladze, A.6
  • 26
    • 77955921192 scopus 로고    scopus 로고
    • Lysine 419 targets human glucocorticoid receptor for proteasomal degradation
    • PMID:20619282
    • Wallace AD, Cao Y, Chandramouleeswaran S, Cidlowski JA. Lysine 419 targets human glucocorticoid receptor for proteasomal degradation. Steroids 2010; 75:1016-23; PMID:20619282; http://dx.doi.org/10.1016/j.steroids.2010.06. 015.
    • (2010) Steroids , vol.75 , pp. 1016-1023
    • Wallace, A.D.1    Cao, Y.2    Chandramouleeswaran, S.3    Cidlowski, J.A.4
  • 27
    • 0043172317 scopus 로고    scopus 로고
    • Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia
    • PMID:12844332
    • Kofler R, Schmidt S, Kofler A, Ausserlechner MJ. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia. J Endocrinol 2003; 178:19-27; PMID:12844332; http://dx.doi.org/10.1677/joe.0.1780019.
    • (2003) J Endocrinol , vol.178 , pp. 19-27
    • Kofler, R.1    Schmidt, S.2    Kofler, A.3    Ausserlechner, M.J.4
  • 28
    • 79959832986 scopus 로고    scopus 로고
    • Glucocorticoid receptor alpha isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: A new mechanism for glucocorticoid resistance
    • PMID:21527497
    • Gross KL, Oakley RH, Scoltock AB, Jewell CM, Cidlowski JA. Glucocorticoid receptor alpha isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance. Mol Endocrinol 2011; 25:1087-99; PMID:21527497; http://dx.doi.org/10.1210/me.2010- 0051.
    • (2011) Mol Endocrinol , vol.25 , pp. 1087-1099
    • Gross, K.L.1    Oakley, R.H.2    Scoltock, A.B.3    Jewell, C.M.4    Cidlowski, J.A.5
  • 29
    • 59849129547 scopus 로고    scopus 로고
    • Molecular mechanisms regulating glucocorticoid sensitivity and resistance
    • PMID:19000736
    • Gross KL, Lu NZ, Cidlowski JA. Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol Cell Endocrinol 2009; 300:7-16; PMID:19000736; http://dx.doi.org/10.1016/j.mce.2008.10.001.
    • (2009) Mol Cell Endocrinol , vol.300 , pp. 7-16
    • Gross, K.L.1    Lu, N.Z.2    Cidlowski, J.A.3
  • 30
    • 0034845924 scopus 로고    scopus 로고
    • Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance
    • (Oxf) PMID:11589680
    • Ruiz M, Lind U, Gåfvels M, Eggertsen G, Carlstedt-Duke J, Nilsson L, et al. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol (Oxf) 2001; 55:363-71; PMID:11589680; http://dx.doi.org/10.1046/j.1365-2265.2001.01323.x.
    • (2001) Clin Endocrinol , vol.55 , pp. 363-371
    • Ruiz, M.1    Lind, U.2    Gåfvels, M.3    Eggertsen, G.4    Carlstedt-Duke, J.5    Nilsson, L.6
  • 31
    • 56949105269 scopus 로고    scopus 로고
    • Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines
    • PMID:18789525
    • Beesley AH, Weller RE, Senanayake S, Welch M, Kees UR. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines. Leuk Res 2009; 33:321-5; PMID:18789525; http://dx.doi.org/10.1016/j.leukres.2008.08.007.
    • (2009) Leuk Res , vol.33 , pp. 321-325
    • Beesley, A.H.1    Weller, R.E.2    Senanayake, S.3    Welch, M.4    Kees, U.R.5
  • 32
    • 27544446055 scopus 로고    scopus 로고
    • Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course
    • PMID:16266991
    • Irving JA, Minto L, Bailey S, Hall AG. Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course. Cancer Res 2005; 65:9712-8; PMID:16266991; http://dx.doi.org/10.1158/0008-5472.CAN-05-1227.
    • (2005) Cancer Res , vol.65 , pp. 9712-9718
    • Irving, J.A.1    Minto, L.2    Bailey, S.3    Hall, A.G.4
  • 33
    • 33750475959 scopus 로고    scopus 로고
    • Crosstalk between nuclear receptors and nuclear factor kappaB
    • PMID:17072333
    • De Bosscher K, Vanden Berghe W, Haegeman G. Crosstalk between nuclear receptors and nuclear factor kappaB. Oncogene 2006; 25:6868-86; PMID:17072333; http://dx.doi.org/10.1038/sj.onc.1209935.
    • (2006) Oncogene , vol.25 , pp. 6868-6886
    • De Bosscher, K.1    Vanden Berghe, W.2    Haegeman, G.3
  • 34
    • 84926111839 scopus 로고    scopus 로고
    • Glucocorticoid resistance
    • PMID:21164266
    • van Rossum EF, van den Akker EL. Glucocorticoid resistance. Endocr Dev 2011; 20:127-36; PMID:21164266.
    • (2011) Endocr Dev , vol.20 , pp. 127-136
    • Van Rossum, E.F.1    Van Den Akker, E.L.2
  • 35
    • 0035900780 scopus 로고    scopus 로고
    • Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids
    • PMID:11555652
    • Wallace AD, Cidlowski JA. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 2001; 276:42714-21; PMID:11555652; http://dx.doi.org/10.1074/jbc.M106033200.
    • (2001) J Biol Chem , vol.276 , pp. 42714-42721
    • Wallace, A.D.1    Cidlowski, J.A.2
  • 36
    • 0026799412 scopus 로고
    • Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex
    • PMID:1383226
    • Wiederrecht G, Hung S, Chan HK, Marcy A, Martin M, Calaycay J, et al. Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex. J Biol Chem 1992; 267:21753-60; PMID:1383226.
    • (1992) J Biol Chem , vol.267 , pp. 21753-21760
    • Wiederrecht, G.1    Hung, S.2    Chan, H.K.3    Marcy, A.4    Martin, M.5    Calaycay, J.6
  • 37
    • 80051667737 scopus 로고    scopus 로고
    • FKBP51-a selective modulator of glucocorticoid and androgen sensitivity
    • PMID:21565552
    • Stechschulte LA, Sanchez ER. FKBP51-a selective modulator of glucocorticoid and androgen sensitivity. Curr Opin Pharmacol 2011; 11:332-7; PMID:21565552; http://dx.doi.org/10.1016/j.coph.2011.04.012.
    • (2011) Curr Opin Pharmacol , vol.11 , pp. 332-337
    • Stechschulte, L.A.1    Sanchez, E.R.2
  • 38
    • 79953854400 scopus 로고    scopus 로고
    • Dexamethasone-induced FKBP51 expression in peripheral blood mononuclear cells could play a role in predicting the response of asthmatics to treatment with corticosteroids
    • PMID:20853021
    • Chun E, Lee HS, Bang BR, Kim TW, Lee SH, Kim JH, et al. Dexamethasone-induced FKBP51 expression in peripheral blood mononuclear cells could play a role in predicting the response of asthmatics to treatment with corticosteroids. J Clin Immunol 2011; 31:122-7; PMID:20853021; http://dx.doi.org/10.1007/s10875-010-9463-9.
    • (2011) J Clin Immunol , vol.31 , pp. 122-127
    • Chun, E.1    Lee, H.S.2    Bang, B.R.3    Kim, T.W.4    Lee, S.H.5    Kim, J.H.6
  • 39
    • 34547887674 scopus 로고    scopus 로고
    • Selective glucocorticoid receptor agonists (SEGRAs): Novel ligands with an improved therapeutic index
    • PMID:17630119
    • Schäcke H, Berger M, Rehwinkel H, Asadullah K. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index. Mol Cell Endocrinol 2007; 275:109-17; PMID:17630119; http://dx.doi.org/10.1016/j.mce.2007.05.014.
    • (2007) Mol Cell Endocrinol , vol.275 , pp. 109-117
    • Schäcke, H.1    Berger, M.2    Rehwinkel, H.3    Asadullah, K.4
  • 40
    • 15044349502 scopus 로고    scopus 로고
    • The hinge region of the androgen receptor plays a role in proteasome-mediated transcriptional activation
    • PMID:15659841
    • Tanner T, Claessens F, Haelens A. The hinge region of the androgen receptor plays a role in proteasome-mediated transcriptional activation. Ann N Y Acad Sci 2004; 1030:587-92; PMID:15659841; http://dx.doi.org/10.1196/annals. 1329.068.
    • (2004) Ann N y Acad Sci , vol.1030 , pp. 587-592
    • Tanner, T.1    Claessens, F.2    Haelens, A.3
  • 41
    • 42449147095 scopus 로고    scopus 로고
    • LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo
    • PMID:18218700
    • López FJ, Ardecky RJ, Bebo B, Benbatoul K, De Grandpre L, Liu S, et al. LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo. Endocrinology 2008; 149:2080-9; PMID:18218700; http://dx.doi.org/10.1210/en.2007-1353.
    • (2008) Endocrinology , vol.149 , pp. 2080-2089
    • López, F.J.1    Ardecky, R.J.2    Bebo, B.3    Benbatoul, K.4    De Grandpre, L.5    Liu, S.6
  • 42
    • 70350523976 scopus 로고    scopus 로고
    • Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts
    • PMID:19877072
    • Gossye V, Elewaut D, Bougarne N, Bracke D, Van Calenbergh S, Haegeman G, et al. Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2009; 60:3241-50; PMID:19877072; http://dx.doi.org/10.1002/art.24963.
    • (2009) Arthritis Rheum , vol.60 , pp. 3241-3250
    • Gossye, V.1    Elewaut, D.2    Bougarne, N.3    Bracke, D.4    Van Calenbergh, S.5    Haegeman, G.6
  • 43
    • 8844276831 scopus 로고    scopus 로고
    • Identification of novel direct transcriptional targets of glucocorticoid receptor
    • U M, U M. PMID:15385927
    • U M, Shen L, Oshida T, Miyauchi J, Yamada M, Miyashita T; U M. Identification of novel direct transcriptional targets of glucocorticoid receptor. Leukemia 2004; 18:1850-6; PMID:15385927; http://dx.doi.org/10.1038/sj. leu.2403516.
    • (2004) Leukemia , vol.18 , pp. 1850-1856
    • Shen, L.1    Oshida, T.2    Miyauchi, J.3    Yamada, M.4    Miyashita, T.5
  • 44
    • 78650911184 scopus 로고    scopus 로고
    • The role of FKBP5 in cancer aetiology and chemoresistance
    • PMID:21119664
    • Li L, Lou Z, Wang L. The role of FKBP5 in cancer aetiology and chemoresistance. Br J Cancer 2011; 104:19-23; PMID:21119664; http://dx.doi.org/10.1038/sj.bjc.6606014.
    • (2011) Br J Cancer , vol.104 , pp. 19-23
    • Li, L.1    Lou, Z.2    Wang, L.3
  • 45
    • 69249228672 scopus 로고    scopus 로고
    • FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt
    • PMID:19732725
    • Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lingle W, et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 2009; 16:259-66; PMID:19732725; http://dx.doi.org/10.1016/j.ccr. 2009.07.016.
    • (2009) Cancer Cell , vol.16 , pp. 259-266
    • Pei, H.1    Li, L.2    Fridley, B.L.3    Jenkins, G.D.4    Kalari, K.R.5    Lingle, W.6
  • 46
    • 39749157043 scopus 로고    scopus 로고
    • Intersection of nuclear receptors and the proteasome on the epigenetic landscape
    • PMID:18095329
    • Kinyamu HK, Jefferson WN, Archer TK. Intersection of nuclear receptors and the proteasome on the epigenetic landscape. Environ Mol Mutagen 2008; 49:83-95; PMID:18095329; http://dx.doi.org/10.1002/em.20360.
    • (2008) Environ Mol Mutagen , vol.49 , pp. 83-95
    • Kinyamu, H.K.1    Jefferson, W.N.2    Archer, T.K.3
  • 47
    • 22344452512 scopus 로고    scopus 로고
    • Alternative effects of the ubiquitin-proteasome pathway on glucocorticoid receptor down-regulation and transactivation are mediated by CHIP, an E3 ligase
    • PMID:15761032
    • Wang X, DeFranco DB. Alternative effects of the ubiquitin-proteasome pathway on glucocorticoid receptor down-regulation and transactivation are mediated by CHIP, an E3 ligase. Mol Endocrinol 2005; 19:1474-82; PMID:15761032; http://dx.doi.org/10.1210/me.2004-0383.
    • (2005) Mol Endocrinol , vol.19 , pp. 1474-1482
    • Wang, X.1    DeFranco, D.B.2
  • 48
    • 77955286666 scopus 로고    scopus 로고
    • C-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics
    • PMID:20498278
    • Adler J, Reuven N, Kahana C, Shaul Y. c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics. Mol Cell Biol 2010; 30:3767-78; PMID:20498278; http://dx.doi.org/10.1128/MCB.00899-09.
    • (2010) Mol Cell Biol , vol.30 , pp. 3767-3778
    • Adler, J.1    Reuven, N.2    Kahana, C.3    Shaul, Y.4
  • 49
    • 80052066877 scopus 로고    scopus 로고
    • Proteotoxic stress targeted therapy (PSTT): Induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib
    • PMID:21444945
    • Neznanov N, Komarov AP, Neznanova L, Stanhope-Baker P, Gudkov AV. Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib. Oncotarget 2011; 2:209-21; PMID:21444945.
    • (2011) Oncotarget , vol.2 , pp. 209-221
    • Neznanov, N.1    Komarov, A.P.2    Neznanova, L.3    Stanhope-Baker, P.4    Gudkov, A.V.5
  • 50
    • 80053299079 scopus 로고    scopus 로고
    • Enhancing proteotoxic stress as an anticancer strategy
    • PMID:21525531
    • Grant S. Enhancing proteotoxic stress as an anticancer strategy. Oncotarget 2011; 2:284-6; PMID:21525531.
    • (2011) Oncotarget , vol.2 , pp. 284-286
    • Grant, S.1
  • 51
    • 80053410931 scopus 로고    scopus 로고
    • Novel insights into the synergistic interaction of Bortezomib and TRAIL: TBid provides the link
    • PMID:21789791
    • Fulda S. Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link. Oncotarget 2011; 2:418-21; PMID:21789791.
    • (2011) Oncotarget , vol.2 , pp. 418-421
    • Fulda, S.1
  • 52
    • 80053442086 scopus 로고    scopus 로고
    • FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy
    • PMID:21941087
    • Pandit B, Gartel AL. FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy. Cell Cycle 2011; 10:3269-73; PMID:21941087; http://dx.doi.org/10.4161/cc.10.19.17735.
    • (2011) Cell Cycle , vol.10 , pp. 3269-3273
    • Pandit, B.1    Gartel, A.L.2
  • 53
    • 34250557905 scopus 로고
    • Chlorophenethylamine derivatives and their conversion into halogen-free compounds
    • Bretschneider H, Biemann K, Sachsenmaier W, Phenylalkanolamines V. Chlorophenethylamine derivatives and their conversion into halogen-free compounds. Monatsh Chem 1948; 78:82-116; http://dx.doi.org/10.1007/BF00942491.
    • (1948) Monatsh Chem , vol.78 , pp. 82-116
    • Bretschneider, H.1    Biemann, K.2    Sachsenmaier, W.3    Phenylalkanolamines, V.4
  • 54
    • 0031743608 scopus 로고    scopus 로고
    • Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
    • PMID:9811723
    • Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72:9873-80; PMID:9811723.
    • (1998) J Virol , vol.72 , pp. 9873-9880
    • Zufferey, R.1    Dull, T.2    Mandel, R.J.3    Bukovsky, A.4    Quiroz, D.5    Naldini, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.